Voice Project’s Best Workplace Award
Lung Foundation Australia is proud to receive a Voice Project’s Best Workplace Award for 2020. This award is given to organisations that have achieved exceptional…
2020-2021 Federal Budget
Lung Foundation Australia welcomes the announcement of the $2.8 billion Pharmaceutical Benefits Scheme New Medicines Funding Guarantee in the 2020-2021 Federal Budget. This will ensure…
2020 PRIME Awards Non-Government Organisation (NGO) of the Year
Lung Foundation Australia is honoured to receive two 2020 PRIME Awards: Non-Government Organisation (NGO) of the Year Award – recognising a huge contribution to the quality of Australian healthcare and improvements to the lives of Australian…
Interim TGA decision will close loopholes for importing liquid nicotine products in Australia
Lung Foundation Australia welcomes the Therapeutic Goods Administration’s (TGA) decision clarifying that nicotine is an addictive and dangerous drug and notes the TGA has restricted…
Record-breaking ($1.1 Mil) funding injection into Pulmonary Fibrosis research
This Pulmonary Fibrosis Awareness Month (September), Lung Foundation Australia will provide the nation’s single-biggest philanthropic investment in dedicated Pulmonary Fibrosis research to the Centre of Research Excellence in Pulmonary Fibrosis (CRE-PF).…
TGA rejects Big Tobacco proposal to sell heated tobacco products
The following statement can be attributed to Lung Foundation Australia CEO Mark Brooke. Lung Foundation Australia strongly supports the final decision by the Therapeutic Goods…
Australians’ lung cancer understanding and attitudes: Summary of survey findings
Independent surveys conducted by PureProfile for Lung Foundation Australia in 2017 (n=1,003) and 2019 (n=1,010) examined lung cancer understanding and attitudes in nationally-representative samples of…
Latest PBAC recommendations for lung cancer treatments
With significant input from members and advocates, Lung Foundation Australia made a number of submissions to the Pharmaceutical Benefits Advisory Committee (PBAC) for the considerations…
Farewell Juliet
Today, Lung Foundation Australia says farewell to our longest standing team member Juliet Brown, COPD Projects and Guidelines Manager. After 15 years, Juliet is moving…
Message from Lung Foundation Australia’s CEO
The Lung Foundation Australia Board and I are taking further advice on the operations of The Australaisian Lung Cancer Trial Group (ALTG). At this time,…